Mastocytosis
📧 Sign up to get email alerts when something new happens for Mastocytosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Study of Factors Regulating Mast Cell Proliferation
This ClinicalTrials.gov update describes a study funded by NIAID investigating factors that regulate mast cell proliferation; the study is c…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Analysis of the Role of IgE Proteoforms in Health and Disease
KU Leuven is updating on a clinical trial studying the role of IgE proteoforms in health and disease, with recruitment ongoing across severa…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Cromoglicate in Mastocytosis [Phase 2]
Phase 2 trial of Cromoglicate for mastocytosis conducted by LEO Pharma was terminated.
-
CLINICAL_TRIALS research · 2024-08-27Clinical Trial Update: Myeloproliferative Neoplasms (MPNs) Patient Registry
An update on the Myeloproliferative Neoplasms (MPNs) Patient Registry sponsored by University Health Network in Toronto, currently recruitin…
-
CLINICAL_TRIALS research · 2024-06-26Clinical Trial Update: Mastocytosis Registry (of Zurich)
A clinical trial registry entry from the University of Zurich for a Mastocytosis and Hypertryptasemia study that is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-06-03Clinical Trial Update: Relationship Between Circulating Sclerostin and Bone Lesions in Patients With Mastocytosis
This clinical trial update describes a study examining whether circulating sclerostin levels are related to bone lesions in patients with ma…
-
CLINICAL_TRIALS research · 2024-05-29Clinical Trial Update: Study of Cellular Heterogeneity in Patients With Mastocytosis [NA]
A clinical study evaluating cellular heterogeneity in patients with mastocytosis; the study is currently not recruiting.
-
CLINICAL_TRIALS trial_result · 2022-01-04Clinical Trial Update: Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate [NA]
Clinical trial update of imatinib mesylate for various myeloproliferative and related neoplasms including CMML, CML, polycythemia vera, hype…
-
CLINICAL_TRIALS trial_result · 2021-10-20Clinical Trial Update: Hydroxychloroquine in Isolated Cutaneous Mastocytosis Patients or Indolent Systemic Mastocytosis With Associated Skin Involvement Patients [Phase 2, Phase 3]
Clinical trial update for hydroxychloroquine in mastocytosis patients across Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2020-04-09Clinical Trial Update: Mast Cell Activation Test in Allergic Disease
Completed clinical trial evaluating a mast cell activation test in allergic diseases; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2018-12-11Clinical Trial Update: Efficacy of AB1010 in Patients With Systemic Indolent Mastocytosis [Phase 2]
Phase 2 clinical trial assessing the efficacy of AB1010 in patients with systemic indolent mastocytosis has completed.
-
CLINICAL_TRIALS trial_result · 2018-12-10Clinical Trial Update: Masitinib in Patients With Mastocytosis With Handicap and Bearing the D816V Mutation [Phase 2]
Phase 2 clinical trial update for masitinib in patients with mastocytosis carrying the D816V mutation has completed.
-
EMA withdrawal · 2018-04-04EMA Refused: Masipro (Masitinib mesilate) — AB Science
EMA refused Masipro (masitinib mesilate) for mastocytosis; the marketing authorization was not granted.
-
CLINICAL_TRIALS research · 2017-11-13Clinical Trial Update: Mechanisms of Action of Photo(Chemo)Therapy in Skin Diseases [NA]
This clinical-trial update reviews the mechanisms by which phototherapy and photochemotherapy exert therapeutic effects in skin diseases. It…
-
CLINICAL_TRIALS research · 2016-11-07Clinical Trial Update: Molecular Mechanisms and Diagnosis of Mastocytosis
A completed clinical trial update examining the molecular mechanisms and diagnostic approaches for mastocytosis.
-
CLINICAL_TRIALS trial_result · 2016-11-03Clinical Trial Update: Study on Mastocytosis for Rupatadine Treatment [Phase 2, Phase 3]
This document reports the completion of phase 2 and phase 3 trials evaluating rupatadine as a treatment for mastocytosis.
-
CLINICAL_TRIALS trial_result · 2016-09-29Clinical Trial Update: Treatment of Indolent Systemic Mastocytosis With PA101 [Phase 2]
A Phase 2 clinical trial evaluating PA101 for indolent systemic mastocytosis has completed.
-
CLINICAL_TRIALS trial_result · 2016-01-18Clinical Trial Update: The Effect of Xolair ® (Omalizumab) in Mastocytosis Patients [Phase 2, Phase 3]
Xolair (omalizumab) has been studied in patients with mastocytosis, and the Phase 2 and Phase 3 trials have completed.
-
CLINICAL_TRIALS research · 2008-03-04Clinical Trial Update: Characteristics of Mast Cells in Mastocytosis
A completed clinical trial update examining the characteristics of mast cells in patients with mastocytosis. The study is sponsored by the N…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Blood Factors in Mastocytosis and Unexplained Anaphylaxis and Flushing
A completed clinical trial sponsored by the National Institute of Allergy and Infectious Diseases studied blood factors in patients with mas…